Hipra aims to develop a vaccine in 100 days against new pandemics

Spanish biotechnology company Hipra is joining a European project that aims to reduce the development time of vaccines and other biological products…

This initiative, called SPEEDCELL, aims to strengthen the continent's response capacity during potential crisis periods.